Поисковый запрос: <.>S=НОВООБРАЗОВАНИЙ МАРКЕРЫ БИОЛОГИЧЕСКИЕ<.> |
Общее количество найденных документов : 204
Показаны документы с 1 по 20 |
|
>1.
| Adarsh K. Highly sensitive C reactive protein (hsCRP) as marker in Head & Neck cancers/K. Adarsh, B. L. Preethi, Arul Ponni // Експериментальна та клінічна фізіологія і біохімія. -Львів, 2017,N N 1.-С.5-11
|
>2.
| Composition of EVs markers under normoxic and hypoxic conditions depends on the expression level of adaptor protein Ruk/CIN85 in mouse renal carcinoma Renca cells/A. Yu. Zhyvolozhnyi [et al // Biopolymers & Cell. -К., 2021. т.Том 37,N N 5.-С.325-334
|
>3.
| Differential expression pattern of AIR, UCKL1, and PKN1 GENES in prostate cancer patients/L. Kovalevska [et al.] // Experimental Oncology. -К., 2022. т.Том 44,N N 1.-С.47-51
|
>4.
| Expression of markers of bone tissue remodeling in breast cancer and prostate cancer cells in vitro/N. Lukianova [et al.] // Experimental Oncology. -К., 2022. т.Том 44,N N 1.-С.39-46
|
>5.
| Expression of miRNA as prognostic markers of renal cell carcinoma course/Yu. Vitruk [et al.] // Experimental Oncology. -К., 2022. т.Том 44,N N 2.-С.132-136
|
>6.
| Kazmirchuk V. The issue of tumor markers and their interpretation/V. Kazmirchuk, A. Halkin // Лікарська справа. Врачебное дело, 2021,N № 3/4.-С.42-44
|
>7.
| Koval'ova O.M. Cytogenetic markers of initiation and progression of cancerogenesis in different strains of mice/O. M. Koval'ova, Yu. I. Kudryavets // Experimental Oncology. -К., 2016. т.Том 38,N N 2.-С.135
|
>8.
| MicroRNA-31 as a potential therapeutic biomarker for oral squamous cell carcinoma:current evidence and future prospects/M. Krishnan [et al.] // Experimental Oncology. -К., 2022. т.Том 44,N N 3.-С.263-264
|
>9.
| Pattern of expression of cancer stem cells markers, CD44 and CD24, in malignant prostate tumors/V. F. Chekhun [et al.] // Experimental Oncology. -К., 2016. т.Том 38,N N 2.-С.131
|
>10.
| PD-L1 тестування як спосіб персонолізації лікування недрібноклітинного раку легень/Ю. В. Москаленко [та ін.] // Лікарська справа. Врачебное дело, 2019,N № 5/6.-С.40-45
|
>11.
| Polyamines as new potential biomarkers for differential diagnosis of prostate cancer and estimation of its aggressiveness/S. P. Zaletok [et al.] // Experimental Oncology. -К., 2022. т.Том 44,N N 2.-С.148-154
|
>12.
| Potential nucleic acid tumor markers in urine samples from patients with prostate cancer/O. S. Mankovska [et al.] // Онкологія. -Київ, 2021. т.Т. 23,N № 4.-С.234
|
>13.
| Relationship aggressiveness of prostate cancer with tumor-associated serum markers/Yu. V. Lozovska [et al.] // Фізіологічний журнал. -К., 2019. т.Том 65,N N 6.-С.70-80
|
>14.
| Sacalo A.V. Newly discovered immunohistochemical markers and micro-RNAs detected in testicular germ-cell tumors/A. V. Sacalo, P. G. Yakovlev // Здоровье мужчины. -Киев, 2016,N N 1.-С.24-26
|
>15.
| Sonatic genomic rearrangements in human leucocyte antigens region in solid ovarian tumors/N. V. Hryshchenko [et al.] // Biopolymers & Cell. -К., 2021. т.Том 37,N N 2.-С.105-116
|
>16.
| Stroi A. A. MicroRNA-508-3p Level in the Blood of Kidney Cancer Patients/A. A. Stroi // Здоровье мужчины, 2017,N № 3.-С.107-109
|
>17.
| The MRPS 18-2 protein as a putative marker of carcinogenesis/M. Mints [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92
|
>18.
| The study of prognostic value of microRNAs (miR-10b and-155) and CDKN2A/ P161NK4A in oral squamous cell carcinoma/O. Kravets [et al.] // Experimental Oncology. -К., 2023. т.Том 45,N N 2.-С.187-194
|
>19.
| Tumor markers from liquid biopsies. Benefits and limitations/O. Mankovska [et al.] // Experimental Oncology. -К., 2018. т.Том 40,N N 2.-С.169
|
>20.
| Validation of a panel of biomarkers associated with aggressive phenotype of endometrioid carcinoma of endometrium/L. G. Buchynska [et al.] // Experimental Oncology. -К., 2022. т.Том 44,N N 3.-С.234-238
|
|
|